Physician
Healing Hands Pediatrics, PLLC
Healing Hands Pediatrics, PLLC was paid $7.38M by Medicaid between Nov 2018 and Dec 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoHEALING HANDS PEDIATRICS, PLLC
DONNA, TX 78537
DONNA, TX 78537
33aNPI1699263822assigned 04/24/2018
33bProvider typeFamily Medicine Physician
28Total paid$7.38M
24GClaims339,732
24DCodes billed61
24AFirst – last monthNov 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#10 of 1,204
Median peer was paid$31K
This provider vs. median240×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38 | $1K | |
| 2019 | 350 | $14K | |
| 2020 | 19,385 | $369K | |
| 2021 | 66,118 | $1.32M | |
| 2022 | 84,142 | $1.75M | |
| 2023 | 78,094 | $1.82M | |
| 2024incomplete | 91,605 | $2.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 69,393 | 61,889 | $2.37M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 15% | 29,465 | 27,199 | $1.14M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 6,407 | 6,204 | $486K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.0% | 32,813 | 30,919 | $442K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.9% | 6,008 | 5,819 | $437K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.8% | 31,693 | 14,978 | $427K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.4% | 5,188 | 4,893 | $402K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 6,967 | 6,538 | $335K |
| S8301 | Infection control supplies, not otherwise specified | 3.7% | 31,378 | 27,649 | $272K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.9% | 3,119 | 2,922 | $215K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 30,469 | 28,250 | $194K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.6% | 17,650 | 7,292 | $190K |
49 more codes
| 99429 | 1.9% | 4,536 | $140K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,308 | $71K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,331 | $40K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 341 | $24K |
| 87807 | <1% | 2,151 | $23K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 998 | $22K |
| 90461 | <1% | 3,095 | $21K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 482 | $21K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,662 | $19K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 584 | $18K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 569 | $17K |
| 99050 | <1% | 882 | $12K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,250 | $12K |
| 96161 | <1% | 5,369 | $10K | |
| 99000 | <1% | 734 | $6K | |
| 81002 | <1% | 1,480 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 48 | $4K |
| 99051 | <1% | 821 | $3K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 287 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 163 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 46 | $2K |
| 17110 | <1% | 15 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 103 | $1K |
| 97169 | <1% | 77 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,323 | $1K |
| 97802 | <1% | 13,998 | $741.00 | |
| 90474 | <1% | 55 | $384.16 | |
| 86580 | <1% | 33 | $255.70 | |
| 83655 | <1% | 316 | $235.18 | |
| 90677 | <1% | 677 | $87.00 | |
| 90686 | <1% | 1,063 | $85.97 | |
| 90651 | <1% | 555 | $31.00 | |
| 90620 | <1% | 139 | $14.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 64 | $7.68 |
| S9451 | Exercise classes, non-physician provider, per session | <1% | 14,041 | $1.35 |
| 90656 | <1% | 33 | $1.00 | |
| 90696 | <1% | 46 | $1.00 | |
| 90670 | <1% | 1,548 | $1.00 | |
| 90734 | <1% | 446 | $1.00 | |
| 90648 | <1% | 432 | $1.00 | |
| 90680 | 0% | 527 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 179 | $0.00 |
| 90697 | 0% | 245 | $0.00 | |
| 90723 | 0% | 53 | $0.00 | |
| 90633 | 0% | 488 | $0.00 | |
| 96160 | 0% | 97 | $0.00 | |
| 90710 | 0% | 424 | $0.00 | |
| 90715 | 0% | 56 | $0.00 | |
| 90700 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTROMAN, PAMELA (CO OWNER)
| Provider | Location | Paid |
|---|---|---|
| Stroman & Gutierrez Family Practice Clinic and Med Spa, PLLC | Weslaco, TX | $496K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.